본문 바로가기
KERD
논문KCI 등재

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose We investigated the clinicopathologic information of patients with gastric cancer with multiple primary cancers (GC-MPC) of three or more sites. Materials and Methods Between 1995 and 2009, 105,908 patients were diagnosed with malignancy at Severance Hospital, Yonsei University Health System. Of these, 113 (0.1%) patients with MPC of three or more sites were registered, and 41 (36.3%) of these were GC-MPC. We retrospectively reviewed the clinical data and overall survival using the medical records of these 41 GC-MPC patients. We defined synchronous cancers as those occurring within 6 months of the first primary cancer, while metachronous cancers were defined as those occurring more than 6 months later. Results Patients with metachronous GC-MPC were more likely to be female (p=0.003) and young than patients with synchronous GC-MPC (p=0.013). The most common cancer sites for metachronous GC-MPC patients were the colorectum, thyroid, lung, kidney and breast, while those for synchronous GC-MPC were the head and neck, esophagus, lung, and kidney. Metachronous GC-MPC demonstrated significantly better overall survival than synchronous GC-MPC, with median overall survival durations of 4.7 and 14.8 years, respectively, and 10-year overall survival rates of 48.2%and 80.7%, respectively (p<0.001). Conclusion Multiplicity of primary malignancies itself does not seem to indicate a poor prognosis. The early detection of additional primary malignancies will enable proper management with curative intent.

Abstract

Purpose We investigated the clinicopathologic information of patients with gastric cancer with multiple primary cancers (GC-MPC) of three or more sites. Materials and Methods Between 1995 and 2009, 105,908 patients were diagnosed with malignancy at Severance Hospital, Yonsei University Health System. Of these, 113 (0.1%) patients with MPC of three or more sites were registered, and 41 (36.3%) of these were GC-MPC. We retrospectively reviewed the clinical data and overall survival using the medical records of these 41 GC-MPC patients. We defined synchronous cancers as those occurring within 6 months of the first primary cancer, while metachronous cancers were defined as those occurring more than 6 months later. Results Patients with metachronous GC-MPC were more likely to be female (p=0.003) and young than patients with synchronous GC-MPC (p=0.013). The most common cancer sites for metachronous GC-MPC patients were the colorectum, thyroid, lung, kidney and breast, while those for synchronous GC-MPC were the head and neck, esophagus, lung, and kidney. Metachronous GC-MPC demonstrated significantly better overall survival than synchronous GC-MPC, with median overall survival durations of 4.7 and 14.8 years, respectively, and 10-year overall survival rates of 48.2%and 80.7%, respectively (p<0.001). Conclusion Multiplicity of primary malignancies itself does not seem to indicate a poor prognosis. The early detection of additional primary malignancies will enable proper management with curative intent.

참고문헌 (25)

  1. Otsuji E, "Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma", Cancer, 82, pp.1233~1237 (1998)
  2. Ikeda Y, "Features of early gastric cancer detected by modern diagnostic technique", J Clin Gastroenterol, 27, pp.60~62 (1998)
  3. Maehara Y, "Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time", Cancer, 70, pp.392~395 (1992)
  4. Hiyama T, "Second primary cancer after diagnosis of stomach cancer in Osaka, Japan", Jpn J Cancer Res, 82, pp.762~770 (1991)
  5. Furukawa H, "Treatments for second malignancies after gastrectomy for stomach cancer", Hepatogastroenterology, 43, pp.194~198 (1996)
  6. Luciani A, "Multiple primary malignancies", Semin Oncol, 31, pp.264~273 (2004)
  7. Németh Z, "Quadruple cancer, including triple cancers in the head and neck region", Neoplasma, 49, pp.412~414 (2002)
  8. Wegner HE, "Multiple primary cancers in urologic patients. Audit of 19-year experience in Berlin and review of the literature", Urology, 39, pp.231~236 (1992)
  9. Salminen E, "Subsequent primary cancers following bladder cancer", Eur J Cancer, 30, pp.303~307 (1994)
  10. Rabbani F, "Multiple primary malignancies in renal cell carcinoma", J Urol, 160, pp.1255~1259 (1998)
  11. Warren S, "Multiple primary, malignant tumors: a survey of the literature and statistical study", Am J Cancer, 16, pp.1358~1414 (1932)
  12. Moertel CG, "Multiple primary malignant neoplasms: historical perspectives", Cancer, 40, pp.1786~1792 (1977)
  13. Hayat MJ, "Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program", Oncologist, 12, pp.20~37 (2007)
  14. Hajdu SI, "Multiple primary malignant tumors", J Am Geriatr Soc, 16, pp.16~26 (1968)
  15. Annual report of Korea Central Cancer Registry, "National Cancer Center", National Cancer Center, ~ (2009)
  16. Inoue M, "Epidemiology of gastric cancer in Japan", Postgrad Med J, 81, pp.419~424 (2005)
  17. Fujino Y, "Cigarette smoking and mortality due to stomach cancer: findings from the JACC Study", J Epidemiol, 15, pp.113~119 (2005)
  18. Furberg AH, "Molecular epidemiology, biomarkers and cancer prevention", Trends Mol Med, 7, pp.517~521 (2001)
  19. Jones PA, "DNA methylation and cancer", Oncogene, 21, pp.5358~5360 (2002)
  20. Slaughter DP, "Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin", Cancer, 6, pp.963~968 (1953)
  21. Begg CB, "Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program", Am J Epidemiol, 142, pp.653~665 (1995)
  22. Levi F, "Second primary cancers in patients with lung carcinoma", Cancer, 86, pp.186~190 (1999)
  23. Ponz de Leon M, "Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group", Dis Colon Rectum, 50, pp.2126~2134 (2007)
  24. Marrano D, "Synchronous and metachronous cancer of the stomach", Eur J Surg Oncol, 13, pp.493~498 (1987)
  25. Moreaux J, "Gastric adenocarcinoma in the gastric stump after partial gastrectomy", Hepatogastroenterology, 38, pp.517~521 (1991)

관련 논문AI추천

Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer김윤년, 김진영, 도영록, 박건욱, 송홍석, Kang Kuk Lee, Mi Hwa Heo, Won Young Jang대한암학회 · Cancer Research and Treatment2012 · 제44권 제3호Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only김규표, 김송철, 류백렬, 박진홍, 박호섭, 서동완, 성유나, 신수진, 유창훈, 이상수, 홍승모, 황대욱대한암학회 · Cancer Research and Treatment2018 · 제50권 제4호Metachronous Double Primary Cancer after Treatment of Breast Cancer김진영, 송홍석대한암학회 · Cancer Research and Treatment2015 · 제47권 제1호위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고강희석, 김병기, 김태중, 배덕수, 이은주, 이정원, 이제호, 최철훈, 최현진대한산부인과학회 · Obstetrics & Gynecology Science2008 · 제51권 제12호Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients김나영, 김영훈, 김지원, 이근욱, 이동호, Ahn Sang-Hoon, Ahn Soyeon, Chang Won, Choi Yonghoon, Jo Hyeong Ho, Kang So Hyun, Kim Hyung Ho, Kim Jin Won, Kim Sangbin, Lee Hye Seung, Lee Kyoung Ho, Lee Yoon Jin, Oh Hyeon Jeong, Park Do Joong, Park Ji Hoon, Park Young Soo, Park Young Suk, Shin Cheol Min, Song Du Hyun, Suh Yun-Suhk, Surh Young-Joon, Yoon Hyuk거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제2호Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms김영백, 김정환, 박형석, 성인경, 심찬섭, 이선영, 한혜승거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제2호

이 간행물의 다른 논문 (9건)